MedPath

Tavotek Lab Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:2
Completed:2

Trial Phases

2 Phases

Phase 1:4
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
4 (80.0%)
Phase 2
1 (20.0%)

A Study of TAVO412 in Patients with Cancer (TAVO412)

Phase 1
Recruiting
Conditions
Cancer
Interventions
First Posted Date
2025-01-07
Last Posted Date
2025-01-16
Lead Sponsor
Tavotek Biotherapeutics
Target Recruit Count
50
Registration Number
NCT06761651
Locations
🇨🇳

Affiliated Cancer Hospital of Chongqing University, Chongqing, Chongqing, China

🇨🇳

First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

🇨🇳

Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China

and more 3 locations

A Study of TAVO101 in Atopic Dermatitis Patients

Phase 2
Active, not recruiting
Conditions
Atopic Dermatitis
Interventions
First Posted Date
2023-12-19
Last Posted Date
2024-11-18
Lead Sponsor
Tavotek Biotherapeutics
Target Recruit Count
20
Registration Number
NCT06176040
Locations
🇦🇺

Royal Melbourne Hospital, Parkville, Victoria, Australia

🇳🇿

Optimal Clinical Trials, Auckland, New Zealand

A Study of TAVO412 in Patients with Cancer

Phase 1
Active, not recruiting
Conditions
Cancer
Interventions
First Posted Date
2022-09-21
Last Posted Date
2024-10-23
Lead Sponsor
Tavotek Biotherapeutics
Target Recruit Count
50
Registration Number
NCT05548634
Locations
🇺🇸

Tisch Cancer Center, NYC, New York, United States

Study of TAVO103A in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Subjects
Interventions
Other: Placebo
First Posted Date
2022-04-06
Last Posted Date
2023-12-12
Lead Sponsor
Tavotek Biotherapeutics
Target Recruit Count
30
Registration Number
NCT05313152
Locations
🇺🇸

ICON, Salt Lake City, Utah, United States

Study of TAVO101 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Subjects
First Posted Date
2022-03-28
Last Posted Date
2024-11-19
Lead Sponsor
Tavotek Biotherapeutics
Target Recruit Count
42
Registration Number
NCT05298046
Locations
🇦🇺

CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia

News

No news found
© Copyright 2025. All Rights Reserved by MedPath